|
67 Companies |
|
98 Products |
|
98 Products |
|
94 Mechanisms of Action |
|
2 Trials |
|
2243 News |
|
| 12345678910111213...4445» |
- | NN1213 / Novo Nordisk
Phase classification: Auricular Acupuncture in the Treatment of Obesity (clinicaltrials.gov) - Aug 6, 2024
P=N/A, N=82, Completed, Sponsor: Mike O'Callaghan Military Hospital
Phase classification: P4 --> P=N/A
- | Enrollment change: Erythrocyte and Adipocyte G6PD Activity Levels in Obesity (clinicaltrials.gov) - May 15, 2024
P=N/A, N=27, Completed, Sponsor: University of South Alabama
Phase classification: P4 --> P=N/A N=16 --> 27
- | Phase classification: ACTION: Adolescents Committed to Nutrition and Physical Activity (clinicaltrials.gov) - Mar 12, 2024
P=N/A, N=145, Completed, Sponsor: University of New Mexico
N=16 --> 27 Phase classification: P1/2 --> P=N/A
- | Trial termination: Child Health Initiative for Lifelong Eating and Exercise (CHILE) (clinicaltrials.gov) - Mar 5, 2024
P=N/A, N=980, Terminated, Sponsor: University of New Mexico
Phase classification: P1/2 --> P=N/A Completed --> Terminated; Based on the primary study completion date, this research does not meet the former definition of a clinical trial.
- | Phase classification: SHINE: Randomized Controlled Clinical Trial of Weight Loss Programs in Obese Persons (clinicaltrials.gov) - Feb 15, 2024
P=N/A, N=194, Completed, Sponsor: University of California, San Francisco
Completed --> Terminated; Based on the primary study completion date, this research does not meet the former definition of a clinical trial. Phase classification: P2 --> P=N/A
- | Trial termination: Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients (clinicaltrials.gov) - Apr 25, 2023
P=N/A, N=50, Terminated, Sponsor: 59th Medical Wing
Completed --> Terminated; Investigator did not submit an annual continuation report with the Institutional Review Board and the study was officially removed from IRB regulatory oversight on Sep 2014, based on 32 CFR 219.109e. The study officially expired/terminated.
- | NN1213 / Novo Nordisk
Enrollment change: Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome (clinicaltrials.gov) - Apr 26, 2019
P=N/A, N=31, Completed, Sponsor: University of Kansas Medical Center
The study officially expired/terminated. N=52 --> 31
- | Phase classification: Dairy Foods and Weight Loss (clinicaltrials.gov) - Apr 24, 2019
P=N/A, N=78, Completed, Sponsor: USDA, Western Human Nutrition Research Center
N=52 --> 31 Phase classification: P2/3 --> P=N/A
- | Phase classification: Evaluating the Transferability of a Successful, Hospital-based, Childhood Obesity Clinic to Primary Care: a Pilot Study (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=106, Completed, Sponsor: University of Bristol
Phase classification: P2/3 --> P=N/A Phase classification: P1 --> P=N/A
- | Phase classification: A Behavioral Intervention for Reducing Obesity (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=56, Completed, Sponsor: UConn Health
Phase classification: P1 --> P=N/A Phase classification: P2 --> P=N/A
- | Trial completion: POWeR: A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=287, Completed, Sponsor: University of Kansas
Phase classification: P2 --> P=N/A Active, not recruiting --> Completed
- | Phase classification: New DIETs: New Dietary Interventions Enhancing the Treatment for Weight Loss (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=63, Completed, Sponsor: University of South Carolina
Active, not recruiting --> Completed Phase classification: P1 --> P=N/A
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: Technology Based Obesity Prevention Project (TeBOPP) (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=101, Completed, Sponsor: Maricopa Integrated Health System
Phase classification: P1 --> P=N/A Recruiting --> Completed | N=500 --> 101
- | NN1213 / Novo Nordisk
Trial completion: Effects of Obesity on Pharmacokinetics of the Levonorgestrel Emergency Contraceptive Pill (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=26, Completed, Sponsor: University of Southern California
Recruiting --> Completed | N=500 --> 101 Active, not recruiting --> Completed
- | Trial completion, Surgery, Bariatric surgery: Adaptation of Human Gut Microbiota to Energetic Restriction (clinicaltrials.gov) - Mar 15, 2019
P=N/A, N=140, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Enrollment change: TFTM: Tools For Teen Moms: Reducing Infant Obesity Risk (clinicaltrials.gov) - Mar 8, 2019
P=N/A, N=164, Completed, Sponsor: Michigan State University
Active, not recruiting --> Completed N=82 --> 164
- | NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial termination: Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity (clinicaltrials.gov) - Feb 22, 2019
P=N/A, N=8, Terminated, Sponsor: Northwell Health
N=82 --> 164 N=15 --> 8 | Trial completion date: Dec 2018 --> Nov 2017 | Suspended --> Terminated; Suspended as we are looking for more durable method/device
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, HEOR, Compliance: Text4Fit: Healthcare Text Messaging to Improve Diet, Physical Activity and Weight Loss in a Pediatric Lipid Clinic (clinicaltrials.gov) - Feb 18, 2019
P=N/A, N=148, Completed, Sponsor: University of Florida
N=15 --> 8 | Trial completion date: Dec 2018 --> Nov 2017 | Suspended --> Terminated; Suspended as we are looking for more durable method/device Recruiting --> Completed | N=300 --> 148
- | Enrollment change: Relationships Between GLP-2 and Markers of Bone Turnover Following Feeding (clinicaltrials.gov) - Feb 15, 2019
P=N/A, N=19, Completed, Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Recruiting --> Completed | N=300 --> 148 N=30 --> 19
- | NN1213 / Novo Nordisk
Enrollment change, HEOR, Bariatric surgery: ROI-LGBP: Return on Investment on Lap Gastric Bypass Regarding Quality of Life (clinicaltrials.gov) - Feb 15, 2019
P=N/A, N=0, Withdrawn, Sponsor: Lund University
N=30 --> 19 N=200 --> 0
- | Trial completion: Effect of Dietary Macronutrient Composition (clinicaltrials.gov) - Feb 6, 2019
P=N/A, N=24, Completed, Sponsor: University of Texas Southwestern Medical Center
N=200 --> 0 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Baby Nutrition and Physical Activity Self-Assessment for Child Care (NAP SACC) Intervention Study (clinicaltrials.gov) - Jan 29, 2019
P=N/A, N=960, Completed, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: "Neuroband": Enhancement of Brain Circuit of Inhibitory Control in Obese Patients Undergoing Gastric Banding (clinicaltrials.gov) - Jan 7, 2019
P=N/A, N=14, Completed, Sponsor: Beth Israel Deaconess Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Surgery: ANE-PROBESE: Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients (clinicaltrials.gov) - Jan 3, 2019
P=N/A, N=2013, Completed, Sponsor: Technische Universit
Active, not recruiting --> Completed Recruiting --> Completed
- | metformin / Generic mfg.
Trial completion: GFMS: Reducing Antipsychotic-Induced Weight Gain in Children With Metformin (clinicaltrials.gov) - Jan 2, 2019
P1, N=96, Completed, Sponsor: Nationwide Children's Hospital
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: The Feeding Dynamic Intervention: Self Regulation of Intake in Preschoolers (clinicaltrials.gov) - Jan 2, 2019
P=N/A, N=70, Completed, Sponsor: Nationwide Children's Hospital
Recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Enrollment change: IMMUNOBEDIA: Study of Immune Response in Obesity and Type 2 Diabetes (clinicaltrials.gov) - Dec 27, 2018
P=N/A, N=101, Completed, Sponsor: Centre Hospitalier Universitaire Dijon
Recruiting --> Completed N=150 --> 101
- | Phase classification: iReach2: Internet Obesity Treatment Enhanced With Motivational Interviewing (clinicaltrials.gov) - Dec 24, 2018
P=N/A, N=495, Completed, Sponsor: University of Vermont
N=150 --> 101 Phase classification: P1 --> P=N/A
- | Trial primary completion date: ObeDi: Influence of Preconceptional Obesity on the Myometrial Cells Differentiation Toward a Contractyl Phenotype (clinicaltrials.gov) - Dec 21, 2018
P=N/A, N=38, Completed, Sponsor: Centre Hospitalier Universitaire Dijon
Phase classification: P1 --> P=N/A Trial primary completion date: Nov 2013 --> Jan 2016
- | Trial completion: Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity (clinicaltrials.gov) - Dec 21, 2018
P4, N=60, Completed, Sponsor: Weill Medical College of Cornell University
Trial primary completion date: Nov 2013 --> Jan 2016 Active, not recruiting --> Completed
- NN1213 / Novo Nordisk
Enrollment change: Obesity Hypoventilation Syndrome Prevalence Study (clinicaltrials.gov) - Dec 11, 2018
P=N/A, N=44, Terminated, Sponsor: Philips Respironics
Active, not recruiting --> Completed N=200 --> 44
- | NN1213 / Novo Nordisk
Trial completion: Whole Body Vibration Training for Healthy Body Composition in Young Adults (clinicaltrials.gov) - Nov 23, 2018
P=N/A, N=176, Completed, Sponsor: Oregon Health and Science University
N=200 --> 44 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial primary completion date, Surgery, Bariatric surgery: Changes in Body Composition Following Bariatric Surgery (clinicaltrials.gov) - Nov 20, 2018
P=N/A, N=136, Completed, Sponsor: Peter Nau
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jul 2018 --> Oct 2018
- | Trial completion, Enrollment change, Surgery, Bariatric surgery: Protein Need and Interest of " Quick Proteins " to the Obese Subject Operated by Bariatric Surgery (BIBOP) (clinicaltrials.gov) - Nov 13, 2018
P=N/A, N=25, Completed, Sponsor: University Hospital, Clermont-Ferrand
Recruiting --> Completed | Trial primary completion date: Jul 2018 --> Oct 2018 Recruiting --> Completed | N=70 --> 25
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: A Skills-based RCT for Physical Activity Using Peer Mentors (clinicaltrials.gov) - Nov 8, 2018
P=N/A, N=805, Completed, Sponsor: Ohio State University
Recruiting --> Completed | N=70 --> 25 Recruiting --> Completed | N=1720 --> 805 | Trial completion date: Oct 2019 --> Nov 2018 | Trial primary completion date: Mar 2019 --> Nov 2018
- | NN1213 / Novo Nordisk
Enrollment change, Trial termination: Aldosterone Antagonism and Microvascular Function (clinicaltrials.gov) - Nov 5, 2018
P4, N=25, Terminated, Sponsor: Maastricht University Medical Center
Recruiting --> Completed | N=1720 --> 805 | Trial completion date: Oct 2019 --> Nov 2018 | Trial primary completion date: Mar 2019 --> Nov 2018 N=60 --> 25 | Recruiting --> Terminated; Failure to recruit sufficient participants
- | Enrollment open, Trial completion date, Trial primary completion date, HEOR: Pilot Project on Interdisciplinary Therapy of Obesity (clinicaltrials.gov) - Oct 26, 2018
P=N/A, N=480, Recruiting, Sponsor: University of Hohenheim
N=60 --> 25 | Recruiting --> Terminated; Failure to recruit sufficient participants Active, not recruiting --> Recruiting | Trial completion date: May 2018 --> May 2029 | Trial primary completion date: May 2018 --> May 2029
- | piperacillin sodium/tazobactam sodium / Generic mfg.
Trial completion date, Trial primary completion date: PK/PD of High Dose Pip/Tazo in Obese Patients (clinicaltrials.gov) - Oct 26, 2018
P=N/A, N=29, Completed, Sponsor: Loma Linda University
Active, not recruiting --> Recruiting | Trial completion date: May 2018 --> May 2029 | Trial primary completion date: May 2018 --> May 2029 Trial completion date: Aug 2016 --> Jan 2016 | Trial primary completion date: Aug 2016 --> Jan 2016
- | Trial completion, Phase classification, Trial completion date: Resveratrol and the Metabolic Syndrome (clinicaltrials.gov) - Oct 24, 2018
P=N/A, N=28, Completed, Sponsor: Rockefeller University
Trial completion date: Aug 2016 --> Jan 2016 | Trial primary completion date: Aug 2016 --> Jan 2016 Active, not recruiting --> Completed | Phase classification: P2 --> PN/A | Trial completion date: Dec 2018 --> Jul 2018
- | NN1213 / Novo Nordisk
Trial completion: Guided Imagery Lifestyle Intervention to Promote Health and Prevent Diabetes in Youth (clinicaltrials.gov) - Oct 17, 2018
P=N/A, N=240, Completed, Sponsor: University of Southern California
Active, not recruiting --> Completed | Phase classification: P2 --> PN/A | Trial completion date: Dec 2018 --> Jul 2018 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Implementation and Validation of the "5As Framework of Obesity Management" in Primary Care. "5AsT" (clinicaltrials.gov) - Oct 16, 2018
P=N/A, N=255, Completed, Sponsor: University of Alberta
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date: Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women (clinicaltrials.gov) - Oct 15, 2018
P=N/A, N=136, Completed, Sponsor: University of Vermont
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=250 --> 136 | Trial completion date: Dec 2018 --> Aug 2017
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: A Trial To Study The Effects Of Group Versus Individual Dietary Counseling In Pediatric Obesity (clinicaltrials.gov) - Oct 12, 2018
P=N/A, N=90, Completed, Sponsor: Albert Einstein College of Medicine, Inc.
Active, not recruiting --> Completed | N=250 --> 136 | Trial completion date: Dec 2018 --> Aug 2017 Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018
- | NN1213 / Novo Nordisk
Trial primary completion date: Aldosterone Antagonism and Microvascular Function (clinicaltrials.gov) - Oct 11, 2018
P4, N=60, Recruiting, Sponsor: Maastricht University Medical Center
Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018 Trial primary completion date: Jun 2018 --> Nov 2018
- | Trial completion: STOPP-8 OM3: Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children (clinicaltrials.gov) - Oct 5, 2018
P=N/A, N=423, Completed, Sponsor: Karolinska Institutet
Trial primary completion date: Jun 2018 --> Nov 2018 Not yet recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Gastric Electrical Stimulation (GES) for the Treatment of Obesity (clinicaltrials.gov) - Oct 2, 2018
P=N/A, N=32, Completed, Sponsor: Medtronic Corporate Technologies and New Ventures
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: Neurohormonal & Behavioral Correlates of Obesity and Weight Loss (clinicaltrials.gov) - Sep 24, 2018
P=N/A, N=16, Completed, Sponsor: University of Michigan
Active, not recruiting --> Completed Enrolling by invitation --> Completed | N=60 --> 16
- | Trial completion: I-care: Stimulating Self-management in Patients With Type 2-diabetes (clinicaltrials.gov) - Sep 24, 2018
P=N/A, N=15, Completed, Sponsor: Oslo and Akershus University College of Applied Sciences
Enrolling by invitation --> Completed | N=60 --> 16 Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Bariatric surgery: Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting (clinicaltrials.gov) - Sep 20, 2018
P=N/A, N=62, Completed, Sponsor: Medical University of South Carolina
Active, not recruiting --> Completed Enrolling by invitation --> Completed | N=150 --> 62
- | Trial completion, Phase classification, Trial completion date: LCD-KBT: Obesity Treatment With LCD in Primary Health Care (clinicaltrials.gov) - Sep 17, 2018
P=N/A, N=174, Completed, Sponsor:
Enrolling by invitation --> Completed | N=150 --> 62 Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Oct 2017 --> Jun 2017